Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,089 | -29,747 | -89,417 | -67,162 | -61,578 |
| Depreciation Amortization | 2,318 | 1,137 | 4,856 | 3,717 | 2,611 |
| Income taxes - deferred | -5,528 | -11,660 | -64,245 | -53,446 | -44,892 |
| Other Working Capital | -52,890 | 12,155 | 194,356 | 94,625 | 128,254 |
| Other Operating Activity | 1,094 | -4,990 | 51,304 | 9,148 | 8,114 |
| Operating Cash Flow | $-81,095 | $-33,105 | $96,854 | $-13,118 | $32,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,061 | -489 | -2,549 | -1,786 | -966 |
| Other Investing Activity | 0 | 0 | 334 | 0 | 0 |
| Investing Cash Flow | $-1,061 | $-489 | $-2,215 | $-1,786 | $-966 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -19,162 | -2,711 | -16,369 | -1,640 | N/A |
| Other Financing Activity | -9,100 | 0 | -269,155 | -259,362 | -259,362 |
| Financing Cash Flow | $-28,262 | $-2,711 | $-285,524 | $-261,002 | $-259,362 |
| Exchange Rate Effect | 1,222 | -970 | -9,590 | -828 | 42 |
| Beginning Cash Position | 304,179 | 304,179 | 504,654 | 504,654 | 504,654 |
| End Cash Position | 194,983 | 266,904 | 304,179 | 227,920 | 276,877 |
| Net Cash Flow | $-109,196 | $-37,275 | $-200,475 | $-276,734 | $-227,777 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,095 | -33,105 | 96,854 | -13,118 | 32,509 |
| Capital Expenditure | -1,061 | -489 | -2,549 | -1,786 | -966 |
| Free Cash Flow | -82,156 | -33,594 | 94,305 | -14,904 | 31,543 |